{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:42:24Z","timestamp":1790743344570,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jbspin.2026.106108","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T15:07:49Z","timestamp":1784128069000},"page":"106108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Liver fibrosis and steatosis in psoriatic arthritis: A real-world elastography-based study"],"prefix":"10.1016","volume":"93","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2556-2512","authenticated-orcid":false,"given":"Clara","family":"Molina Almela","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2064-5324","authenticated-orcid":false,"given":"Cristina","family":"Campos Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Latorre S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Andr\u00e9s","family":"Rom\u00e1n Ivorra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jbspin.2026.106108_bib0165","first-page":"426","article-title":"Management of psoriatic arthritis in patients with comorbidities: an updated literature review informing the 2021 GRAPPA treatment recommendations","volume":"50","author":"Campanholo","year":"2023","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.jbspin.2026.106108_bib0170","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jbspin.2019.12.004","article-title":"Cardiovascular risk in psoriatic arthritis, a narrative review","volume":"87","author":"Verhoeven","year":"2020","journal-title":"Joint Bone Spine"},{"issue":"3","key":"10.1016\/j.jbspin.2026.106108_bib0175","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","author":"Tacke","year":"2024","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.jbspin.2026.106108_bib0180","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202149641","article-title":"The \u201cDomino effect\u201d in MASLD: the inflammatory cascade of steatohepatitis","volume":"54","author":"Mladeni\u0107","year":"2024","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jbspin.2026.106108_bib0185","doi-asserted-by":"crossref","first-page":"152165","DOI":"10.1016\/j.semarthrit.2023.152165","article-title":"Psoriatic disease and non-alcoholic fatty liver disease shared pathogenesis review","volume":"59","author":"Torosian","year":"2023","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.jbspin.2026.106108_bib0190","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s13679-023-00519-y","article-title":"The role of tumor necrosis factor-alpha in the pathogenesis and treatment of nonalcoholic fatty liver disease","volume":"12","author":"Vachliotis","year":"2023","journal-title":"Curr Obes Rep"},{"issue":"13","key":"10.1016\/j.jbspin.2026.106108_bib0195","doi-asserted-by":"crossref","first-page":"7405","DOI":"10.3390\/ijms25137405","article-title":"Exploring fibrosis pathophysiology in lean and obese metabolic-associated fatty liver disease: an in-depth comparison","volume":"25","author":"Veskovi\u0107","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.jbspin.2026.106108_bib0200","first-page":"517","article-title":"Non-alcoholic fatty liver disease and psoriasis-is there a shared proinflammatory network?","volume":"19","author":"Heitmann","year":"2021","journal-title":"J German Soc Dermatol"},{"key":"10.1016\/j.jbspin.2026.106108_bib0205","doi-asserted-by":"crossref","first-page":"907729","DOI":"10.3389\/fimmu.2022.907729","article-title":"Immunological risk factors for nonalcoholic fatty liver disease in patients with psoriatic arthritis: new predictive nomograms and natural killer cells","volume":"13","author":"Li","year":"2022","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.jbspin.2026.106108_bib0210","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1111\/jdv.16273","article-title":"The role of the interleukin-23\/Th17 pathway in cardiometabolic comorbidity associated with psoriasis","volume":"34","author":"Egeberg","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.jbspin.2026.106108_bib0215","first-page":"1179","article-title":"D\u00edaz-Miguel P\u00e9rez C. HLA-Cw6 allele and biologic therapy are protective factors against liver fibrosis in psoriatic arthritis patients","volume":"41","author":"Mac\u00eda-Villa","year":"2023","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"10.1016\/j.jbspin.2026.106108_bib0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2024.105763","article-title":"Evolution of FIB-4 score in SpA and PsA patients taking anti-TNF or anti-IL17","volume":"91","author":"Verhoeven","year":"2024","journal-title":"Joint Bone Spine"},{"issue":"5","key":"10.1016\/j.jbspin.2026.106108_bib0225","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis","volume":"65","author":"Dulai","year":"2017","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jbspin.2026.106108_bib0230","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis-2021 update","volume":"75","author":"Berzigotti","year":"2021","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.jbspin.2026.106108_bib0235","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/ajd.13175","article-title":"Prevalence of non-alcoholic fatty liver and liver fibrosis in patients with moderate-severe psoriasis: a cross-sectional cohort study","volume":"61","author":"Magdaleno-Tapial","year":"2020","journal-title":"Australas J Dermatol"},{"issue":"9","key":"10.1016\/j.jbspin.2026.106108_bib0240","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1001\/jamadermatol.2019.0721","article-title":"Prevalence of advanced liver fibrosis in patients with severe psoriasis","volume":"155","author":"Maybury","year":"2019","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jbspin.2026.106108_bib0245","doi-asserted-by":"crossref","first-page":"1068157","DOI":"10.3389\/fmed.2022.1068157","article-title":"Liver fibrosis prevalence and risk factors in patients with psoriasis: a systematic review and meta-analysis","volume":"9","author":"Yongpisarn","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jbspin.2026.106108_bib0250","article-title":"Liver fibrosis 4 score: use in the evaluation of non-alcoholic fatty liver disease in patients with psoriatic arthritis","author":"I\u00f1iguez Ubiaga","year":"2023","journal-title":"Reumatol Clin (Engl Ed)"},{"issue":"4","key":"10.1016\/j.jbspin.2026.106108_bib0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0290632","article-title":"Predictors for liver fibrosis in non-alcoholic patients with psoriatic diseases: a multicenter cross sectional-study","volume":"19","author":"Chavez-Tapia","year":"2024","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jbspin.2026.106108_bib0260","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keaf640","article-title":"FIB-4 as an effective screening tool in psoriatic arthritis patients at high-risk for liver disease: a cross-sectional study using FibroScan","volume":"65","author":"Meridor","year":"2026","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"10.1016\/j.jbspin.2026.106108_bib0265","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1007\/s10067-019-04646-7","article-title":"Metabolic syndrome, non-alcoholic fatty liver disease and liver stiffness in psoriatic arthritis and psoriasis patients","volume":"38","author":"Ortolan","year":"2019","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.jbspin.2026.106108_bib0270","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.cgh.2019.05.051","article-title":"Development and validation of hepamet fibrosis scoring system-a simple, noninvasive test to identify patients with nonalcoholic fatty liver disease with advanced fibrosis","volume":"18","author":"Ampuero","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.jbspin.2026.106108_bib0275","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3390\/diagnostics11010098","article-title":"Liver fibrosis biomarkers accurately exclude advanced fibrosis and are associated with higher cardiovascular risk scores in patients with NAFLD or viral chronic liver disease","volume":"11","author":"Ballestri","year":"2021","journal-title":"Diagnostics"},{"issue":"16","key":"10.1016\/j.jbspin.2026.106108_bib0280","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation."},{"issue":"4","key":"10.1016\/j.jbspin.2026.106108_bib0285","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003100","article-title":"Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of population-based observational studies","volume":"17","author":"Jarvis","year":"2020","journal-title":"PLoS Med"},{"key":"10.1016\/j.jbspin.2026.106108_bib0290","doi-asserted-by":"crossref","first-page":"7963972","DOI":"10.1155\/2016\/7963972","article-title":"Liver stiffness measurement in psoriasis: do metabolic or disease factors play the important role?","volume":"2016","author":"Pongpit","year":"2016","journal-title":"Biomed Res Int"},{"issue":"5","key":"10.1016\/j.jbspin.2026.106108_bib0295","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jbspin.2026.106108_bib0300","article-title":"Hyperuricemia in psoriatic arthritis: epidemiology, pathophysiology, and clinical implications","volume":"8","author":"Tripolino","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"11","key":"10.1016\/j.jbspin.2026.106108_bib0305","doi-asserted-by":"crossref","first-page":"5741","DOI":"10.1093\/rheumatology\/keaf344","article-title":"High prevalence of MASLD in psoriasis and psoriatic arthritis assessed with multiparametric magnetic resonance imaging","volume":"64","author":"James","year":"2025","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.jbspin.2026.106108_bib0310","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jhep.2022.12.034","article-title":"Risk of liver fibrosis associated with long-term methotrexate therapy may be overestimated","volume":"78","author":"Atallah","year":"2023","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.jbspin.2026.106108_bib0315","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41584-022-00883-4","article-title":"Busting the myth of methotrexate chronic hepatotoxicity","volume":"19","author":"Di Martino","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jbspin.2026.106108_bib0320","first-page":"168","article-title":"Decoding clinical and molecular pathways of liver dysfunction in psoriatic arthritis: impact of cumulative methotrexate doses","volume":"1","author":"Ruiz-Ponce","year":"2023","journal-title":"Biomed Pharmacother"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X26000771?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X26000771?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T20:13:43Z","timestamp":1788380023000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X26000771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S1297319X26000771"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2026.106108","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liver fibrosis and steatosis in psoriatic arthritis: A real-world elastography-based study","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2026.106108","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Soci\u00e9t\u00e9 Fran\u00e7aise de Rhumatologie. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106108"}}